Dr. Reddy's Laboratories/RDY

$76.83

-0.33%
-
1D1W1MYTD1YMAX

About Dr. Reddy's Laboratories

Dr. Reddy’s Laboratories Limited is an India-based global pharmaceutical company. The Company offers a portfolio of products and services, including active pharmaceutical ingredients (APIs), generics, branded generics, biosimilars and over-the-counter (OTC). Its major therapeutic areas of focus are gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. The Company’s segments include Pharmaceutical Services and Active Ingredients, Global Generics, and Others. The Pharmaceutical Services and Active Ingredients segment primarily consists of the Company’s business of manufacturing and marketing APIs and intermediates. The Global Generics segment consists of the Company’s business of manufacturing and marketing prescription and OTC finished pharmaceutical products ready for consumption by the patient, marketed under a brand name (branded formulations) or as generic finished dosages with therapeutic equivalence to branded formulations (generics).

Ticker

RDY

Sector

Healthcare

Trading on

NYSE

Industry

Biotechnology & Drugs

CEO

Gunupati Prasad

Employees

25,863

Headquarters

Hyderabad, India

RDY Metrics

BasicAdvanced
$12.94B
Market cap
20.38
P/E ratio
$3.78
EPS
0.59
Beta
$0.48
Dividend rate
0.63%
Dividend yield

What the Analysts think about RDY

Analyst Ratings

Majority rating from 3 analysts.
Buy

Price Targets

Average projection from 3 analysts.
1.95% upside
High $80.04
Low $75.91
$76.83
Current price
$78.33
Average price target

RDY Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
19.11% profit margin
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
₹72.15B
4.86%
Net income
₹13.79B
-6.83%
Profit margin
19.11%
-11.16%

RDY Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 17.58%
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
₹57.62
₹84.36
₹88.91
₹82.81
-
Expected
₹52.50
₹57.03
₹69.65
₹70.43
₹56.19
Surprise
9.74%
47.93%
27.65%
17.58%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.
ADR

Upcoming events

Buy or sell Dr. Reddy's Laboratories stock

Buy or sell Dr. Reddy's Laboratories stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing